UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 256

Sortiert nach

An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer

Oncogene, 2012-04, Vol.31 (16), p.2090-2100

2012

Volltextzugriff (PDF)

Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia

Leukemia, 2017-01, Vol.31 (1), p.51-57

2017

Volltextzugriff (PDF)

Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia

Leukemia, 2014-08, Vol.28 (8), p.1738-1742

2014

Volltextzugriff (PDF)

Rad51c- and Trp53-double-mutant mouse model reveals common features of homologous recombination-deficient breast cancers

Oncogene, 2016-09, Vol.35 (35), p.4601-4610

2016

Volltextzugriff (PDF)

Monitoring therapy responses at the leukemic subclone level by ultra-deep amplicon resequencing in acute myeloid leukemia

Leukemia, 2017-05, Vol.31 (5), p.1048-1058

2017

Volltextzugriff (PDF)

Cytokinesis failure due to derailed integrin traffic induces aneuploidy and oncogenic transformation in vitro and in vivo

Oncogene, 2012-08, Vol.31 (31), p.3597-3606

2012

Volltextzugriff (PDF)

Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response

Breast cancer targets and therapy, 2017-01, Vol.9, p.185-198

2017

Volltextzugriff (PDF)

Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia

European journal of cancer (1990), 2016-07, Vol.61, p.S136-S136

2016

Volltextzugriff (PDF)

681 Aneuploidy Facilitates Oncogenic Transformation Via Specific Genetic Alterations

European journal of cancer (1990), 2012-07, Vol.48, p.S161-S161

2012

Volltextzugriff (PDF)

338 The HER2 Amplicon Includes Several Genes Required for the Growth and Survival of HER2 Positive Breast Cancer Cells

European journal of cancer (1990), 2012-07, Vol.48, p.S82-S83

2012

Volltextzugriff (PDF)

5003 ORAL Inhibition of HER2 Positive Breast Cancer Cells by Drug Screening

European journal of cancer (1990), 2011, Vol.47, p.S330-S331

2011

Volltextzugriff (PDF)

Case studies investigating genetic heterogeneity between anatomically distinct bone marrow compartments in acute myeloid leukemia

Leukemia & lymphoma, 2018-12, Vol.59 (12), p.3002-3005

2018

Volltextzugriff (PDF)

Optimized LOWESS normalization parameter selection for DNA microarray data

BMC bioinformatics, 2004-12, Vol.5 (1), p.194-194

2004

Volltextzugriff (PDF)

Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer

BMC cancer, 2016-07, Vol.16 (1), p.378, Article 378

2016

Volltextzugriff (PDF)

612 - Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia

European journal of cancer (1990), 2016-07, Vol.61, p.S136-S136

2016

Volltextzugriff (PDF)

Are data from different gene expression microarray platforms comparable?

Genomics (San Diego, Calif.), 2004-06, Vol.83 (6), p.1164-1168

2004

Volltextzugriff (PDF)

558 Systematic functional analysis of microRNAs by transfection of 1129 miRNAs into prostate cancer cells

European journal of cancer supplements, 2010, Vol.8 (7), p.177-177

2010

Volltextzugriff (PDF)

Interactions between Notch- and hypoxia-induced transcriptomes in embryonic stem cells

Experimental cell research, 2010-05, Vol.316 (9), p.1610-1624

2010

Volltextzugriff (PDF)

Abnormal expression of apoptosis‐related genes in haematological malignancies: overexpression of MYC is poor prognostic sign in mantle cell lymphoma

British journal of haematology, 2003-02, Vol.120 (3), p.434-441

2003

Volltextzugriff (PDF)

Integrative functional genomics analysis of sustained polyploidyphenotypes in breast cancer cells identifies an oncogenic profile for GINS2

Neoplasia (New York, N.Y.), 2010-11, Vol.12 (11)

2010

Volltextzugriff (PDF)

A novel strategy for microarray quality control using Bayesian networks

Bioinformatics, 2003-11, Vol.19 (16), p.2031-2038

2003

Volltextzugriff (PDF)

NMD microarray analysis for rapid genome-wide screen of mutated genes in cancer

Analytical cellular pathology (Amsterdam), 2005, Vol.27 (3), p.169-173

2005

Volltextzugriff (PDF)

A strategy for identifying putative causes of gene expression variation in human cancers

Journal of the Franklin Institute, 2004, Vol.341 (1), p.77-88

2004

Volltextzugriff (PDF)

Studying DNA microarray data using independent component analysis

First International Symposium on Control, Communications and Signal Processing, 2004, 2004, p.747-750

2004

Volltextzugriff (PDF)

Systematic functional analysis of microRNAs by transfection of 1129 miRNAs into prostate cancer cells

22nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics,2010-11-16 - 2010-11-19, 2010, Vol.8 (7), p.177

2010

Volltextzugriff (PDF)

1 – 25 von 256

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(219)
Mit Volltextzugriff
(213)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

An integrated genomic approach identifies ARID1A as a candidate tumor-suppressor gene in breast cancer

Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia

Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia

Rad51c- and Trp53-double-mutant mouse model reveals common features of homologous recombination-deficient breast cancers

Monitoring therapy responses at the leukemic subclone level by ultra-deep amplicon resequencing in acute myeloid leukemia

Cytokinesis failure due to derailed integrin traffic induces aneuploidy and oncogenic transformation in vitro and in vivo

Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response

Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia

681 Aneuploidy Facilitates Oncogenic Transformation Via Specific Genetic Alterations

338 The HER2 Amplicon Includes Several Genes Required for the Growth and Survival of HER2 Positive Breast Cancer Cells

5003 ORAL Inhibition of HER2 Positive Breast Cancer Cells by Drug Screening

Case studies investigating genetic heterogeneity between anatomically distinct bone marrow compartments in acute myeloid leukemia

Optimized LOWESS normalization parameter selection for DNA microarray data

Systematic drug screening reveals specific vulnerabilities and co-resistance patterns in endocrine-resistant breast cancer

612 - Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia

Are data from different gene expression microarray platforms comparable?

558 Systematic functional analysis of microRNAs by transfection of 1129 miRNAs into prostate cancer cells

Interactions between Notch- and hypoxia-induced transcriptomes in embryonic stem cells

Abnormal expression of apoptosis‐related genes in haematological malignancies: overexpression of MYC is poor prognostic sign in mantle cell lymphoma

Integrative functional genomics analysis of sustained polyploidyphenotypes in breast cancer cells identifies an oncogenic profile for GINS2

A novel strategy for microarray quality control using Bayesian networks

NMD microarray analysis for rapid genome-wide screen of mutated genes in cancer

A strategy for identifying putative causes of gene expression variation in human cancers

Studying DNA microarray data using independent component analysis

Systematic functional analysis of microRNAs by transfection of 1129 miRNAs into prostate cancer cells

Suchergebnisse filtern